Tristan M Sissung

Title: Innovations by Inventor Tristan M Sissung

Introduction

Tristan M Sissung is a notable inventor based in Annandale, VA (US). He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. With a total of 2 patents, his work focuses on improving prognostic predictions and treatment outcomes for patients.

Latest Patents

One of Sissung's latest patents is related to the SLCO1B3 genotype. This invention involves methods for identifying and predicting inter-patient differences in prognostic prediction for survival in androgen-independent prostate cancer. It also includes methods for determining if a subject has prostate cancer, aiming to enhance medical outcomes. Another significant patent addresses ABCB1 genotyping to predict microtubule-stabilizing-agent-induced toxicity. This disclosure provides methods for identifying subjects at an increased risk of developing adverse side effects from microtubule-stabilizing agents. The presence of specific ABCB1 predictive polymorphisms indicates a higher likelihood of such adverse effects, allowing for tailored therapy modifications.

Career Highlights

Throughout his career, Sissung has worked with prominent organizations, including the United States Department of Health and Human Services and Universitätsklinikum Freiburg. His research has contributed to advancements in understanding cancer treatment and patient care.

Collaborations

Sissung has collaborated with esteemed colleagues such as William Douglas Figg and Alex Sparreboom. These partnerships have furthered his research and innovation in the medical field.

Conclusion

Tristan M Sissung's contributions to medical research through his patents demonstrate his commitment to improving patient outcomes in cancer treatment. His innovative approaches continue to influence the field positively.